# AtriCure to acquire SentreHEART for up to $300M

AtriCure entered a definitive agreement to acquire SentreHEART, a developer of left atrial appendage management solutions. The deal includes $40M upfront in cash and stock plus up to $260M in contingent consideration.

- Type: Acquisition
- Announced: 2019-08-12
- Where: United States
- Value: $300.0M
- Status: announced
- Products: left atrial appendage management solutions, LARIAT device
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [AtriCure](https://endata.com/companies/41277.md) (acquirer)
- [SentreHEART](https://endata.com/companies/41278.md) (target)

## Sources

- [ir.atricure.com](https://ir.atricure.com/news-releases/news-release-details/atricure-enters-definitive-agreement-acquire-sentreheart), 2019-08-12: "We believe that SentreHEART is a strategic addition to AtriCure, significantly expanding our addressable markets with a product designed for electrophysiologists."
- [cardiacrhythmnews.com](https://cardiacrhythmnews.com/atricure-agrees-to-buy-lariat-developer-sentreheart/), 2019-09-16: "We believe that SentreHEART is a strategic addition to AtriCure, significantly expanding our addressable markets with a product designed for electrophysiologists."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.